Nautilus Biotechnolgy, Inc.
Status: Publicly traded
Direct answer
Nautilus Biotechnolgy, Inc. is publicly traded on NASDAQ under the ticker NAUT.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution...
Can you invest in Nautilus Biotechnolgy, Inc.?
Yes. Nautilus Biotechnolgy, Inc. is publicly traded on NASDAQ under the ticker NAUT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nautilus Biotechnolgy, Inc.
Detailed equity research is provided by MarketSnap.